Gotham Asset Management’s Definium Therapeutics DFTX Stock Holding History

Gotham Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208K	Buy	+4,412	New	+$109K	﹤0.01%	1728
2026 Q1	–	Sell	-17,825	Closed	-$239K	–	1825
2025 Q4	$239K	Buy	17,825 +823	+5%	+$10.2K	﹤0.01%	1626
2025 Q3	$200K	Buy	17,002 +2,924	+21%	+$27.3K	﹤0.01%	1616
2025 Q2	$91.4K	Buy	+14,078	New	+$92.6K	﹤0.01%	1620

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Gotham Asset Management's DFTX Position: Q2 2026 in Review

Gotham Asset Management opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 4,412 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #1728 among its holdings. This is a return to the name: Gotham Asset Management previously reported a position in DFTX as recently as Q4 2025.

Gotham Asset Management first reported a position in DFTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $239K in Q4 2025. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Gotham Asset Management held 4,412 shares of Definium Therapeutics worth $208K as of Q2 2026.
Definium Therapeutics was a new Gotham Asset Management position in Q2 2026.
Definium Therapeutics made up ﹤0.01% of Gotham Asset Management's portfolio in Q2 2026, its #1728 holding.
Gotham Asset Management first reported a position in Definium Therapeutics in Q2 2025 and has held it in 4 quarters since.
Gotham Asset Management's Definium Therapeutics position peaked at $239K in Q4 2025.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.